Trial Profile
A phase II randomized study evaluating the safety and efficacy of ABT-510 in subjects with locally advanced or metastatic soft tissue sarcoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2008
Price :
$35
*
At a glance
- Drugs ABT 510 (Primary)
- Indications Sarcoma; Soft tissue sarcoma
- Focus Therapeutic Use
- 01 Nov 2008 Results published in the Journal of Clinical Oncology.
- 20 Sep 2005 New trial record.